Is methylene blue dosed by body weight?

No. Every human oral study of methylene blue used a flat fixed dose, not a mg/kg calculation. The mg/kg figures you see quoted — 0.5, 1, or 2 mg/kg — come from intravenous clinical dosing (the methemoglobinemia antidote is 1-2 mg/kg IV) or from rodent injection studies. Neither transfers to an oral supplement. Use the flat 5 / 10 / 20mg schedule regardless of what you weigh.

Can I take methylene blue every day?

Daily use within the 5-20mg range is the common pattern. Some people cycle 5 days on, 2 days off, or 8 weeks on and 2 weeks off. Cycling is a community convention borrowed from general supplement practice — no trial data supports or refutes it for methylene blue. Consistency matters more than the cycle you pick, because a stable daily dose is what makes any change you observe interpretable.

Should I take methylene blue with food?

Taking it in the morning with food is the standard recommendation and can reduce mild nausea. Absorption is good either way — a controlled crossover study found roughly 72% absolute oral bioavailability for aqueous methylene blue (Walter-Sack et al., 2009). Avoid grapefruit juice, which inhibits CYP3A4 metabolism.

Can I take methylene blue at night?

Morning dosing is strongly recommended. Methylene blue may support cellular energy production and alertness, which can interfere with sleep if taken in the evening. Most protocols specify morning administration with water and food.

What if I miss a dose of methylene blue?

Simply take your next dose at the normal time — do not double up. Missing occasional doses does not meaningfully change the picture. If you miss multiple days in a row, resume at your established dose rather than restarting the titration.

How many drops of methylene blue should I take?

Drops vary by concentration. A 1% solution contains roughly 0.5mg per drop, so 10 drops is about 5mg and 20 drops is about 10mg. A 0.5% solution needs double the drops. Always verify your product's concentration on the label — miscounting drops is the most common way people end up far off their intended dose. Capsules remove the arithmetic entirely.

Is methylene blue safe for children?

Methylene blue supplements are formulated for adults. Pediatric use of methylene blue is limited to FDA-approved medical applications (e.g., methemoglobinemia treatment) under physician supervision at hospital dosing. Do not give methylene blue supplements to children. Consult a pediatrician for any questions about pediatric use.

Do methylene blue capsules stain your mouth?

No. Capsules dissolve in the stomach, which avoids contact with the tongue and oral tissues. Sublingual troches and liquid drops held or swallowed via the mouth are the primary sources of the blue-tongue staining that methylene blue is known for.

How to Take Methylene Blue: Complete Dosing Guide

Learning how to take methylene blue orally is simpler than most guides make it look, because the answer is a flat schedule rather than a calculation: 5mg to start, 10mg as the target, 20mg as the ceiling. This guide covers choosing your format (capsules vs. drops vs. sublingual), working out exactly how many drops of methylene blue per day your concentration works out to, and where the honest limits of the evidence sit. Whether you're asking "how much methylene blue per day" or starting your first protocol, this is your definitive reference.

Methylene Blue Ultra USP-grade capsules in a pharmaceutical lab setting

Dosing Methods Compared

Methylene blue is available in three primary formats. Each has distinct advantages depending on your goals and tolerance for the characteristic blue staining.

Method	Pros	Cons	Best For
Capsules	No staining, precise dose, easy to swallow	Fixed dose sizes, less flexibility	Daily supplementation, beginners
Liquid Drops	Flexible dosing, sublingual option available	Stains teeth and tongue, requires calculation	Dose titration, experienced users
Sublingual	Faster absorption, bypasses first-pass metabolism	Significant staining, inconvenient for daily use	Acute cognitive support, occasional use

Capsules avoid oral staining entirely while keeping oral bioavailability in the same range as other swallowed formats (see the bioavailability comparison below). Most capsules on the market are sold at 10mg, which lines up with the target dose below. If you are still choosing a product, compare methylene blue supplements side by side before settling on a protocol.

How Many Drops of Methylene Blue Per Day

If you're using liquid methylene blue, the number of drops depends entirely on the concentration of your solution. This is critical — a 1% solution contains 5x more methylene blue per drop than a 0.1% solution.

Concentration	mg per Drop	Drops for 5mg (start)	Drops for 10mg (target)	Drops for 20mg (ceiling)
0.1% solution	~0.05mg	100 drops	200 drops	400 drops
0.5% solution	~0.25mg	20 drops	40 drops	80 drops
1% solution	~0.5mg	10 drops	20 drops	40 drops
2% solution	~1.0mg	5 drops	10 drops	20 drops

Warning: Concentration varies significantly by brand. Always verify your product's concentration on the label. When in doubt, use our dosage calculator to convert your concentration into drops. For daily use, capsules remove the drop-counting error and oral staining trade-off.

How Much Methylene Blue Per Day

Oral methylene blue is dosed as a flat daily amount, not as a calculation against your body weight. Start at 5mg/day, hold for at least a week, then move to 10mg/day — the target, and the serving size most capsules on the market are sold at. 20mg/day is the routine ceiling, and it does not move up for heavier or more experienced users.

Phase	Daily Dose	Hold Before Changing	What It Is For
Start	5 mg	At least 7 days	Establishing tolerance before anything else changes
Target	10 mg	14 days, then stop titrating	The destination. Matches the most common capsule size sold
Ceiling	20 mg	Not a scheduled step	Routine upper bound — no exceptions for bodyweight or experience

Where this schedule comes from — and where it doesn't. No published randomized controlled trial has tested chronic daily oral methylene blue in healthy adults for cognitive or mitochondrial endpoints. The 5–10mg range is an extrapolation, anchored to what human oral studies do establish: 10mg orally is well absorbed in healthy men^[4], oral methylene blue has roughly 72% absolute bioavailability^[1], and chronic oral dosing at far higher amounts (69–228mg/day for 24 weeks) was tolerated in an elderly patient population^[5]. The 20mg ceiling is editorial judgment anchored to market serving sizes, not a study. Anyone quoting a precise optimal daily dose for healthy adults is extrapolating too — most just don't say so.

Why there is no weight-based dose

Every human oral study of methylene blue used a flat fixed dose. The mg/kg figures that circulate in dosing guides are not oral supplement doses at all — they come from two other places. The methemoglobinemia antidote is dosed at 1–2 mg/kg intravenously under clinical supervision. The hormetic “sweet spot” and dose-reversal numbers come from rodents given roughly 50 mg/kg by injection^[7]. Neither converts into a capsule you swallow, and multiplying either by your bodyweight produces a number with no human oral evidence behind it.

What the human oral studies actually showed

The cognitive findings people cite for methylene blue come from single large doses, not daily supplementation. A single 280mg oral dose improved memory-retrieval accuracy by about 7% versus placebo in 26 healthy adults^[2]. A single 260mg oral dose improved fear-extinction retention^[3]. Those are 26–28 times the 10mg target dose. They establish that oral methylene blue reaches the brain and does something measurable; they do not establish that 10mg a day reproduces it.

Four different thresholds, four different meanings

“Toxic dose” is used loosely for four unrelated endpoints with different routes and different populations. Collapsing them into one number is how bad dosing advice gets made.

Endpoint	Threshold	Route / Population
Serotonin toxicity	No safe floor established	Any route. Categorical with any serotonergic drug — methylene blue is a potent MAO-A inhibitor^[6]
Paradoxical methemoglobinemia	≥7 mg/kg cumulative	Intravenous. The same drug that treats it at 1–2 mg/kg IV causes it at higher cumulative IV doses
Hemolysis in G6PD deficiency	Any dose	Any route. Absolute contraindication, not a dose question
Hormetic reversal	~50 mg/kg IP	Injected, in rats^[7]. Never a human oral number

To see the schedule laid out against dates, use our interactive dosage calculator.

When to Take Methylene Blue

Time of Day

Morning is recommended. Methylene blue has a mild stimulating effect that may support mitochondrial ATP production at low doses. Taking it in the evening may interfere with sleep in sensitive individuals. Most protocols specify morning dosing with water.

With or Without Food

Either works. Empty stomach may yield slightly faster absorption. Taking with fat (eggs, avocado, olive oil) may enhance bioavailability. If you experience nausea, taking with food reduces GI effects.

Cycling Protocols

5 on / 2 off and 8 weeks on / 2 weeks off are common in biohacking communities. Both are convention, not evidence — no trial data supports or refutes cycling for methylene blue. Continuous daily dosing at 5–10mg is equally defensible.

Avoid Combinations

Never combine with SSRIs, SNRIs, or MAOIs — risk of serotonin syndrome (FDA warning). Avoid grapefruit juice (CYP3A4 inhibition). See our safety guide for full contraindications.

Step-by-Step: Starting Methylene Blue for the First Time

If you've never taken methylene blue before, this is the whole protocol. It takes three weeks end to end and involves exactly one dose increase.

1

Start at 5mg per day

Take 5mg in the morning with food. This is the entry dose regardless of body weight — oral methylene blue is not dosed by mg/kg. If your product is a 10mg capsule, start with a 5mg product rather than splitting capsules, which gives an unreliable dose.

2

Hold 5mg for at least 7 days

Stay at 5mg for a minimum of seven days before changing anything. Blue-green urine is normal and expected — it indicates excretion, not a problem. Watch for nausea, headache, or dizziness. If any appear, hold longer or stop.

3

Move to 10mg per day

After seven well-tolerated days, increase to 10mg per day, taken the same way — morning, with food. 10mg is the target, not a step toward something larger. It is also the most common serving size sold, so it is a dose you can actually buy and repeat.

4

Hold 10mg for 14 days, then stop titrating

Run 10mg for a full 14 days. At the end of that hold the titration is finished. There is no scheduled step to a higher dose — the routine ceiling is 20mg per day and most people have no reason to approach it.

5

Keep the dose stable and log it

Once you settle, keep the dose and the timing constant. A stable daily dose is the only thing that makes an observed change interpretable. Changing dose and schedule at the same time makes any result uninterpretable.

Once the dose is stable, the 90-day protocol covers what to track over the following months.

Safety Considerations

Methylene blue has an established safety profile at evidence-based doses, but there are critical contraindications you must understand before starting.

Absolute Contraindications

SSRI/SNRI/MAOI users: Risk of serotonin syndrome (FDA warning)
G6PD deficiency: Risk of hemolytic anemia
Pregnancy/breastfeeding: Insufficient safety data

See our complete safety guide for full contraindications.

Expected Effects

Blue-green urine: 100% expected, not harmful
Blue stool: Normal excretion sign
Mild energy increase: Possible, especially first week

These are not side effects — they are signs the compound is being processed normally.

Methylene Blue Cycling: 5 Days On, 2 Days Off

Cycling a supplement means alternating periods of use with planned breaks. The 5-days-on 2-days-off pattern is a precautionary convention drawn from general supplement cycling practices for hormetic compounds — substances where the biological response depends on dose and duration. It is commonly used in biohacker communities to give receptor systems a scheduled recovery window and to surface whether the daily subjective response comes from the compound or from routine. No randomized controlled trial data specifically validates or refutes cycling for methylene blue; it is a community convention rather than a clinical requirement.

The 5-on-2-off protocol

The most widely used schedule takes methylene blue for five consecutive days — typically Monday through Friday at a consistent morning dose — and pauses for two days on the weekend. Dosing returns to the same flat daily amount (5–10 mg for most people, 20 mg ceiling) on the next cycle; cycling is not a reason to dose higher on the on-days. The two-day off-period is short enough that MB's elimination half-life (~5–6 hours plasma, longer tissue) does not reset baseline exposure to zero, but long enough to observe whether the subjective state changes without dosing.

Alternative cycles

A few alternative patterns appear in community protocols. 4-on-3-off aligns the dosing week with a Monday–Thursday workweek, leaving a full three-day weekend off-cycle. Some users prefer this when stacking with other biohacking interventions on weekends. 8-weeks-on-2-weeks-off is a longer-horizon cycle used by people running extended protocols with formal measurement checkpoints — the longer off-block creates a wider contrast window for subjective and biomarker assessment. A small cohort runs continuous daily dosing with no cycle at all; chronic uninterrupted dosing is what the human oral literature has actually studied. Every one of these patterns is convention rather than evidence — pick whichever fits your schedule and measurement cadence.

Signs to cycle off

Self-monitoring checkpoints — not diagnostic symptoms — that users commonly flag as reasons to introduce a cycle break: diminishing subjective response to a previously effective dose, altered sleep onset or depth, a persistent low-grade headache that tracks dose timing, or a plateau in the biomarker or performance metric you're tracking. For a full list of what to watch for, see our common side effects guide. These are heuristics, not medical advice; consult a healthcare provider if anything feels clinically significant.

How to track effectiveness

Cycling is most informative when paired with consistent measurement. Journal subjective energy, cognition, and sleep daily, and keep dose + timing in the same log. The dosage calculator lays out the titration schedule, and the MB log captures anonymous dose timing so you can correlate cycle phases with subjective state. Without a log, the signal from a cycle break gets lost in everyday variance.

Sublingual vs Oral: Bioavailability Tradeoffs

Methylene blue is delivered through three common routes: sublingual (troches or drops held under the tongue), oral capsules, and liquid drops swallowed directly. The three differ meaningfully on bioavailability, staining, dosing precision, and daily convenience. No head-to-head RCT data compares clinical outcomes between routes in healthy adults — the choice is practical, not efficacy-gated.

Bioavailability comparison

The 95% sublingual / 70% oral bioavailability figures are commonly cited in biohacker literature, but no peer-reviewed study has actually measured sublingual bioavailability for methylene blue specifically — treat that 95% figure as unverified. What the literature does establish: a controlled crossover study (Walter-Sack et al., 2009, European Journal of Clinical Pharmacology) found about 72% absolute bioavailability for oral aqueous methylene blue, with the liver metabolizing the remaining portion via first-pass metabolism. Sublingual absorption should produce faster onset by partially bypassing that first-pass step, but whether it meaningfully increases total bioavailability for methylene blue specifically remains unestablished.

Route comparison at a glance

Factor	Sublingual	Oral capsule	Liquid drops
Bioavailability	Not established for MB	~72% (Walter-Sack 2009)	~72% (Walter-Sack 2009)
Onset	15–30 min	30–60 min	30–60 min
Oral staining	Yes (blue tongue)	None	Yes (blue tongue)
Dosing precision	Moderate	High (fixed mg)	Variable (drop size)
Daily convenience	Low (hold-time)	High	Medium

When each route makes sense

Sublingual is the route to pick when absolute peak bioavailability matters and you're willing to accept oral staining during the hold-time window. Oral capsules are the default for daily protocol use — consistent fixed dosing, zero staining, easy to take with food. Liquid drops are the most flexible for titration (you can adjust drop-by-drop) but require accepting both staining and dosing variability. For a 90-day protocol where the goal is stable daily exposure, capsules minimize the variables that could confound your subjective or biomarker tracking.

Why fixed-dose capsules simplify the schedule

A capsule shell dissolves in the stomach rather than releasing into the mouth, so the format avoids staining. More useful for a titration: each capsule is a fixed-dose unit, which means the dose you take is the dose you log — no drop-counting, no volumetric measurement errors, no taste management. Because the schedule on this page is a flat 5mg then 10mg, a 5mg and a 10mg capsule cover the whole protocol without any splitting or measuring. For longitudinal protocols where the variable under study is the compound and not the delivery method, the trade is deliberate: you give up some onset speed to remove dosing noise from your data.

Compared across 25+ active methylene blue brands, the sublingual and drops formats dominate shelf space in the biohacking space, while capsules remain a smaller share of the category. That gap is driven more by supply-chain convention than by clinical superiority of one route over another — methylene blue USP powder is harder to encapsulate at consistent purity and dose than it is to measure into a dropper. The tradeoff surface across routes is practical and personal: pick the one that minimizes the variables you don't want to manage.

Stacking Protocols: MB + CoQ10, PQQ, NAD+

Stacking, in the biohacker sense, means taking methylene blue alongside other mitochondrial cofactors that appear in published research on cellular energy and redox balance. Stacks are community-protocol conventions — combinations that show up repeatedly in biohacker forums and practitioner writeups — not RCT-validated regimens. Head-to-head human trials on MB + cofactor combinations are scarce. What follows are the three most-cited pairings, stated as combinations people use and not as efficacy claims.

MB + CoQ10

Coenzyme Q10 appears extensively in mitochondrial function research as a carrier within the electron transport chain. Pairing with methylene blue is common in biohacker community protocols on the theory that both touch cellular energy pathways. There is no head-to-head RCT establishing the combination is more effective than either alone; the pairing is widely used but not clinically validated as synergistic.

MB + PQQ

Pyrroloquinoline quinone (PQQ) has been investigated in research on mitochondrial biogenesis. Community protocols commonly combine it with methylene blue when the user is focused on long-horizon mitochondrial health rather than acute cognitive effect. Same caveat: no head-to-head RCT establishes synergy, and the safety profile of the combination has not been formally characterized in healthy adults.

MB + NAD+ precursors (NR, NMN)

Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the two most-studied NAD+ precursors and have independent research on cellular aging. The MB + NAD+ precursor pairing is a staple of longevity-focused community protocols but lives almost entirely in practitioner-writeup territory rather than clinical trials. Treat this stack the same way: a documented community convention, not a tested combination.

Across all three pairings, the honest summary is the same: these are combinations that show up in community protocols and practitioner writeups, not regimens with published RCT evidence of synergy or superiority. Track cycles with a single-variable change discipline — add one cofactor at a time, not multiple — so you can actually tell which component is doing what. For full stack protocols including dosing sequencing and timing considerations across the common pairings, see our stacks guide. Consult a healthcare provider before combining supplements, particularly if you take prescription medications.

Frequently Asked Questions

Start at 5mg per day, hold there for at least 7 days, then move to 10mg per day if you tolerate it well. 10mg is the destination, not a waypoint — most capsules sold are 10mg, and there is no reason to keep climbing once you get there. 20mg per day is the routine ceiling. Be clear about what these numbers are: no published randomized controlled trial has tested chronic daily oral methylene blue in healthy adults for cognitive or mitochondrial endpoints, so the 5-10mg schedule is an extrapolation from single-dose human studies and market serving sizes, not a validated protocol.

Most users report no noticeable effects for the first 2-4 weeks. Mitochondrial adaptation is gradual — reported benefits typically accumulate over 4-12 weeks of consistent use. Do not judge efficacy based on the first week. Note that the single-dose human studies showing acute cognitive effects used far larger doses (260-280mg) than any daily supplement schedule, so they do not predict what a 10mg daily dose will feel like.

Signs to act on include persistent nausea, headache, dizziness, or chest discomfort. If any of these appear, drop back to your previous dose or stop and consult a healthcare provider. Separately from tolerance, there are four unrelated thresholds worth knowing, and none of them is a single 'toxic dose': serotonin toxicity has no established safe floor and is categorical with any serotonergic drug; paradoxical methemoglobinemia is documented at 7 mg/kg or more of cumulative intravenous methylene blue; hemolysis in G6PD deficiency can occur at any dose; and the hormetic reversal often quoted online comes from rats given roughly 50 mg/kg by injection, not from humans taking capsules.

In controlled single-dose studies, yes — but at doses far above any supplement schedule. A single 280mg oral dose improved memory-retrieval accuracy by about 7% versus placebo in 26 healthy adults (Rodriguez et al., 2016, Radiology), and a single 260mg oral dose improved fear-extinction retention (Telch et al., 2014). Nothing in the literature establishes that 5-10mg daily reproduces those acute effects. Treat single-dose findings as evidence that oral methylene blue reaches the brain and does something measurable, not as a promise about a daily capsule.

Methylene blue is commonly combined with mitochondrial cofactors like CoQ10, PQQ, and NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide) in community protocols. Those combinations appear in mitochondrial research independently, but no head-to-head trial has established synergy with methylene blue — treat them as conventions, not tested regimens. The interaction to avoid is serotonergic compounds (SSRIs, SNRIs, MAOIs, 5-HTP, St. John's Wort) due to serotonin toxicity risk.

The 5-on-2-off protocol means taking methylene blue for five consecutive days followed by a two-day break. It is drawn from general supplement cycling conventions and is common in biohacker communities. No trial data validates or refutes this schedule for methylene blue — it is convention, not evidence. Alternative cycles include 4-on-3-off (weekend-aligned) and 8-weeks-on 2-weeks-off for longer-horizon protocols with formal measurement checkpoints.

Sublingual administration produces faster onset by partially bypassing first-pass hepatic metabolism, but the bioavailability advantage is less clear-cut than often claimed. The best available data — a controlled crossover study (Walter-Sack et al., 2009, European Journal of Clinical Pharmacology) — found about 72% absolute bioavailability for oral aqueous methylene blue; no peer-reviewed study has directly measured sublingual bioavailability for methylene blue specifically. Sublingual routes also cause oral staining (blue tongue) and less precise dosing; capsules provide consistent fixed dosing without the staining tradeoff. The choice is mainly about onset speed vs. staining and precision, not a proven efficacy win for either route.

Ready to Map Out Your Titration?

Our dosage calculator lays out the 5 → 10mg schedule against real dates, with built-in SSRI safety warnings.

Use Dosage Calculator View 90-Day Protocol

Related Guides: Methylene Blue Safety, Science & Brands

References

[1]Walter-Sack I, Rengelshausen J, Oberwittler H, et al. (2009). High absolute bioavailability of methylene blue given as an aqueous oral preparation. European Journal of Clinical Pharmacology 65:179-189. 10.1007/s00228-008-0563-x
[2]Rodriguez P, Zhou W, Barrett DW, et al. (2016). Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. PMC5084971
[3]Telch MJ, Bruchey AK, Rosenfield D, et al. (2014). Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. American Journal of Psychiatry (PMID 25018057).
[4]DiSanto AR, Wagner JG (1972). Pharmacokinetics of highly ionized drugs II: methylene blue — absorption, metabolism, and excretion in man and dog after oral administration. Journal of Pharmaceutical Sciences 61(7):1086-1090.
[5]Wischik CM, Staff RT, Wischik DJ, et al. (2015). Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease. Journal of Alzheimer's Disease (PMID 25550228).
[6]Ramsay RR, Dunford C, Gillman PK (2007). Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. PMC2078225
[7]Bruchey AK, Gonzalez-Lima F (2008). Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. American Journal of Pharmacology and Toxicology. PMC2867617